Cmg Drug Patent Portfolio
Cmg owns 1 orange book drug protected by 1 US patent Given below is the list of Cmg's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9694008 | Fast-dissolving oral film preparation comprising aripiprazole | 07 Aug, 2033 | Active |
Latest Legal Activities on Cmg's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cmg.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 03 Oct, 2024 | US9694008 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 29 Jul, 2020 | US9694008 |
| Patent Issue Date Used in PTA Calculation | 04 Jul, 2017 | US9694008 |
| Recordation of Patent Grant Mailed | 04 Jul, 2017 | US9694008 |
| Email Notification | 15 Jun, 2017 | US9694008 |
| Issue Notification Mailed | 14 Jun, 2017 | US9694008 |
| Dispatch to FDC | 01 Jun, 2017 | US9694008 |
| Application Is Considered Ready for Issue | 31 May, 2017 | US9694008 |
| Response to Reasons for Allowance | 30 May, 2017 | US9694008 |
| Issue Fee Payment Received | 30 May, 2017 | US9694008 |
| Issue Fee Payment Verified | 30 May, 2017 | US9694008 |
| Email Notification | 12 May, 2017 | US9694008 |
| Filing Receipt - Corrected | 12 May, 2017 | US9694008 |
| Mail Notice of Allowance | 12 Apr, 2017 | US9694008 |
| Electronic Review | 12 Apr, 2017 | US9694008 |
Cmg's Family Patents
Cmg Drug List
Given below is the complete list of Cmg's drugs and the patents protecting them.
1. Mezofy
Mezofy is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9694008 | Fast-dissolving oral film preparation comprising aripiprazole |
07 Aug, 2033
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mezofy's drug page